Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2000-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.20.2.493PMID 10669648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PLASMA HOMOCYSTEINE LEVELS AND MORTALITY IN PATIENTS WITH CORONARY ARTERY DISEASE

  2000cited by this paper
• Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

  1998cited by this paper
• Plasma homocysteine levels and mortality in patients with coronary artery disease.

  1997cited by this paper
• Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease.

  1997cited by this paper
• A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.

  1997cited by this paper
• Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial.

  1997cited by this paper
• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

  1997cited by this paper
• Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

  1997cited by this paper
• Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women.

  1997cited by this paper
• A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.

  1996cited by this paper
• Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.

  1996cited by this paper
• Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis.

  1996cited by this paper
• Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women > or = 55 years of age.

  1996cited by this paper
• Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

  1996cited by this paper
• Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.

  1996cited by this paper
• Lipoprotein(a), Plasmin Modulation, and Atherogenesis

  1995cited by this paper
• Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.

  1995cited by this paper
• Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.

  1995cited by this paper
• Lipoprotein (a) and coronary heart disease.

  1995cited by this paper
• Serum total homocysteine and coronary heart disease.

  1995influential reference
• Lipoprotein(a) and coronary heart disease.

  1994cited by this paper
• A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.

  1994cited by this paper
• Synthesis and transsulfuration of homocysteine in blood.

  1994cited by this paper
• Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects.

  1994cited by this paper
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

  1994cited by this paper
• Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.

  1994cited by this paper
• Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

  1994cited by this paper
• Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

  1994cited by this paper
• Total homocysteine in plasma or serum: methods and clinical applications.

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37).

  1993cited by this paper
• Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.

  1992cited by this paper
• Atherogenesis in transgenic mice expressing human apolipoprotein(a)

  1992cited by this paper
• The effect of blood sample aging and food consumption on plasma total homocysteine levels.

  1992cited by this paper
• Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

  1992cited by this paper
• Homocysteine export from erythrocytes and its implication for plasma sampling.

  1992cited by this paper
• Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men.

  1992cited by this paper
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

  1991cited by this paper
• High Performance Liquid Chromatography Method for Rapid and Accurate Determination of Homocysteine in Plasma and Serum

  1991cited by this paper
• Lipoprotein (a). Heterogeneity and biological relevance.

  1990cited by this paper
• Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

  1990cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Incidence and prognostic significance of intraventricular conduction abnormalities after coronary bypass surgery.

  1990cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• Isolation of apolipoprotein(a) from lipoprotein(a).

  1985cited by this paper
• General relative risk functions for case-control studies.

  1985cited by this paper
• Interaction between discrete causes.

  1981cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Clinical, Biochemical, and Coronary Angiographic Profiling of Symptomatic Premature Coronary Artery Disease in a Gujarati Population: A Cross-Sectional Study.

  2026cites this paper
• N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity

  2022cites this paper
• Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy

  2021cites this paper
• Soy isoflavones and phytate: Effects on homocysteine, C-reactive protein, and iron status in postmenopausal women

  2020cites this paper
• A SHORT STUDY ON THE CLINICO PATHOLOGICAL CORRELATION OF SERUM HOMOCYSTEINE LEVEL

  2020cites this paper
• Increased plasma level of lipoprotein(a) and homocysteine is a marker of increased cardiovascular risk

  2019cites this paper
• Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis[S]

  2019cites this paper
• STUDY OF CORONARY ARTERY DISEASE IN PATIENTS OF YOUNGER AGE GROUP LESS THAN 40 YEARS OF AGE

  2018cites this paper
• Correlation between homocysteine levels and stroke in patients with acute ischemic stroke

  2018cites this paper
• Challenges in Predicting Risks of Premature Coronary Artery Disease (PCAD)

  2018cites this paper
• Homocystein im Brennpunkt

  2018cites this paper
• B vitamins in stroke prevention: time to reconsider.

  2017cites this paper
• Interaction Between Vitamin D and Lipoprotein (a) on the Presence and Extent of Coronary Heart Disease.

  2017cites this paper
• JOURNAL FÜR ERNÄHRUNGSMEDIZIN

  2017cites this paper
• Coronary Artery Disease Clinical Characteristics of Patients Less than Forty Years Old with Coronary Artery Disease in Taiwan : A Cross-Sectional Study

  2017cites this paper
• Risk Factors among Young Saudi Male Patients who underwent Coronary Revascularization (PCI or CABG)

  2017cites this paper
• Clinical Characteristics of Patients Less than Forty Years Old with Coronary Artery Disease in Taiwan: A Cross-Sectional Study.

  2017cites this paper
• Atherothrombotic non-ST segment elevation myocardial infarction in a 42-year-old white female with no known cardiovascular risk factors

  2016cites this paper
• Lipoprotein (a) and biochemical parameters in elderly

  2016cites this paper
• What are the Predictors of Coronary Artery Disease in Young Saudi Arabian Patients

  2015cites this paper
• Thrombophilia as a cardiovascular risk factor for acute myocardial infarction at young age – case report

  2015cites this paper
• Coronary Artery Disease in Young Adults

  2015cites this paper
• Role of homocysteinylation of ACE in endothelial dysfunction of arteries.

  2015cites this paper
• Lipoprotein (a): a Unique Independent Risk Factor for Coronary Artery Disease

  2015cites this paper
• Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk.

  2014cites this paper
• Choroba wieńcowa w populacji młodych dorosłych: skala problemu, czynniki ryzyka i rokowanie — przegląd literatury

  2014cites this paper
• Homocysteine Level According to Some Cardiac Risk Factors and Extent of Coronary Disease

  2013cites this paper
• Comparison of the Clinical Efficacy of Bovine Thrombin and Compression Method in Femoral Pseudoaneurysm of Patients Undergoing Percutaneous Coronary Intervention

  2013cites this paper
• Dysfunctional HDL-cholesterol: a potential link between high levels of HDL-cholesterol and cardiovascular disease?

  2013cites this paper
• The effects of lipoprotein(a) and homocysteine on prognosis and risk factors in acute ischemic stroke

  2013cites this paper
• Homocysteine in Protein Structure/Function and Human Disease

  2013cites this paper
• Cardiovascular Disease Risk Tests

  2013cites this paper
• S-Homocysteinylated Proteins

  2013cites this paper
• Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.

  2012cites this paper
• EFFECT OF FOLIC ACID SUPPLEMENTATION ON THE PROGRESSION OF CAROTID INTIMA-MEDIA THICKNESS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS

  2012cites this paper
• Lipoprotein(a) and homocysteine potentiate the risk of coronary artery disease in male subjects.

  2012cites this paper
• Lipoprotein a levels in pediatric migraine.

  2011cites this paper
• Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease

  2011cites this paper
• Nutrition and human health from a sex-gender perspective.

  2011cites this paper
• Role of homocysteine and lipoprotein (A) in atherosclerosis: An update

  2011cites this paper
• Comparison of the Clinical Efficacy of Bovine Thrombin and Compression Method in Femoral Pseudo Aneurysm of Patients Undergoing per Coetaneous Coronary Intervention at Shaheed Rajaie Cardiovascular Medical and Research Center

  2011cites this paper
• Hiperhomocysteinemia u chorych na pierwotne nadciśnienie tętnicz

  2011cites this paper
• APPROACH TO POSTMENOPAUSAL CARDIOVASCULAR RISK Review Article

  2011cites this paper
• Role of intestinal transporters in neonatal nutrition: carbohydrates, proteins, lipids, minerals, and vitamins.

  2010cites this paper
• A young soldier with syncope, shortness of breath and palpitations.

  2010cites this paper
• Homocysteine and lipoprotein (a) correlation in ischemic stroke patients.

  2009influential citation
• Dyslipidemia in South Asians living in a western community.

  2009cites this paper
• The relation between coronary lesion distribution and risk factors in young adults.

  2009influential citation
• Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers.

  2009cites this paper
• Role of lipoprotein(a) in cardiovascular disease current and future perspectives.

  2008cites this paper
• Lipoprotein(a), homocysteine, and retinal arteriosclerosis

  2008influential citation
• Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke

  2008cites this paper
• ole of Lipoprotein ( a ) in ardiovascular Disease urrent and Future Perspectives

  2008cites this paper
• Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults.

  2007cites this paper
• Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency.

  2007cites this paper
• Lipoprotein(a) and LDL Particle Size Are Related to the Severity of Coronary Artery Disease

  2007cites this paper
• Immunoregulatory effects of homocysteine on cardiovascular diseases.

  2007cites this paper
• Molecular Targeting of Proteins by L-Homocysteine: Mechanistic Implications for Vascular Disease

  2007cites this paper
• Folate and vitamin B12 status of a multiethnic adult population.

  2006cites this paper
• Elevated lipoprotein(a)--a genetic risk factor for premature vascular disease in people with and without standard risk factors: a review.

  2006cites this paper
• Lipoprotein(a): a unique risk factor for cardiovascular disease.

  2006cites this paper
• Resistance Training Lowers Exercise‐Induced Oxidative Stress and Homocysteine Levels in Overweight and Obese Older Adults

  2006influential citation
• Women and Coronary Heart Disease

  2006cites this paper
• Homocysteine, vitamin B12 and folate levels in premature coronary artery disease

  2006influential citation
• C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.

  2006cites this paper
• Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac‐1 integrin

  2006cites this paper
• Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein

  2005cites this paper
• Myocardial infarction in young adults

  2005cites this paper
• Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.

  2005cites this paper
• Plasma homocysteine and lipoprotein (a) levels in Turkish patients with metabolic syndrome

  2005cites this paper
• Relevance of post‐methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients

  2005cites this paper
• Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma

  2005cites this paper
• Molecular targeting by homocysteine: a mechanism for vascular pathogenesis

  2005cites this paper
• Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study

  2005cites this paper
• Homocysteinämie und B-Vitamine - Rationeller Umgang mit einem neuen Risikofaktor

  2004cites this paper
• Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.

  2004cites this paper
• Berglund and Ramakrishnan Lipoprotein ( a ) : An Elusive Cardiovascular Risk Factor 2221

  2004cites this paper
• DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations

  2004cites this paper
• Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases

  2004cites this paper
• Lipoprotein(a): an elusive cardiovascular risk factor.

  2004cites this paper
• Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease

  2004cites this paper
• Sex-specific associations of lipoprotein(a) with presence and quantity of coronary artery calcification in an asymptomatic population.

  2004cites this paper
• Premature coronary artery disease: Clinical risk factors and prognosis

  2004cites this paper
• [Effect of lipoprotein (a) on the risk of coronary heart disease in adults aged less than 65 years in function of gender differences].

  2003cites this paper
• Artery Disease by Decreasing

  2003cites this paper
• Coronary artery disease in young adults.

  2003cites this paper
• Konsensuspapier der D.A.CH.-Liga Homocystein über den rationellen klinischen Umgang mit Homocystein, Folsäure und B-Vitaminen bei kardiovaskulären und thrombotischen Erkrankungen - Richtlinien und Empfehlungen

  2003cites this paper
• Monitoring delirium in critically ill patients. Using the confusion assessment method for the intensive care unit.

  2003cites this paper
• Lipoproteína(a) y aterotrombosis

  2003cites this paper
• Reducing coronary artery disease by decreasing homocysteine levels.

  2003cites this paper
• Adipositas und Herz: Neue Risikofaktoren und Surrogatendpunkte

  2003cites this paper
• DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations

  2003cites this paper
• HYPERHOMOCYSTEINEMIA: GENETIC POLYMORPHISMS AND RISK OF CORONARY ARTERY DISEASE

  2003cites this paper
• Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N‐acetylcysteine therapy

  2003cites this paper
• Emerging Risk Factors for Atherosclerotic Vascular Disease

  2003cites this paper
• Efecto de la lipoproteína (a) en el riesgo de enfermedad coronaria en adultos menores de 65 años en función del sexo

  2003cites this paper
• Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

  2003cites this paper
• Omocisteina nei pazienti diabetici tipo 1 e nelle loro famiglie

  2003cites this paper
• Lipoprotein(a): An Emerging Cardiovascular Risk Factor

  2003cites this paper
• Homocysteine and lipoprotein levels following resistance training in older adults.

  2003cites this paper